ID   LEG9_BOVIN              Reviewed;         355 AA.
AC   Q3MHZ8;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2005, sequence version 1.
DT   03-AUG-2022, entry version 92.
DE   RecName: Full=Galectin-9;
DE            Short=Gal-9;
GN   Name=LGALS9;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Hereford; TISSUE=Ascending colon;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Binds galactosides. Has high affinity for the Forssman
CC       pentasaccharide. Ligand for HAVCR2/TIM3. Binding to HAVCR2 induces T-
CC       helper type 1 lymphocyte (Th1) death. Also stimulates bactericidal
CC       activity in infected macrophages by causing macrophage activation and
CC       IL1B secretion which restricts intracellular bacterial growth. Ligand
CC       for P4HB; the interaction retains P4HB at the cell surface of Th2 T
CC       helper cells, increasing disulfide reductase activity at the plasma
CC       membrane, altering the plasma membrane redox state and enhancing cell
CC       migration. Ligand for CD44; the interaction enhances binding of SMAD3
CC       to the FOXP3 promoter, leading to up-regulation of FOXP3 expression and
CC       increased induced regulatory T (iTreg) cell stability and suppressive
CC       function. Promotes ability of mesenchymal stromal cells to suppress T-
CC       cell proliferation. Expands regulatory T-cells and induces cytotoxic T-
CC       cell apoptosis following virus infection. Activates ERK1/2
CC       phosphorylation inducing cytokine (IL-6, IL-8, IL-12) and chemokine
CC       (CCL2) production in mast and dendritic cells. Inhibits degranulation
CC       and induces apoptosis of mast cells. Induces maturation and migration
CC       of dendritic cells. Inhibits natural killer (NK) cell function. Can
CC       transform NK cell phenotype from peripheral to decidual during
CC       pregnancy. Astrocyte derived galectin-9 enhances microglial TNF
CC       production. May play a role in thymocyte-epithelial interactions
CC       relevant to the biology of the thymus. May provide the molecular basis
CC       for urate flux across cell membranes, allowing urate that is formed
CC       during purine metabolism to efflux from cells and serving as an
CC       electrogenic transporter that plays an important role in renal and
CC       gastrointestinal urate excretion. Highly selective to the anion urate.
CC       {ECO:0000250|UniProtKB:O00182, ECO:0000250|UniProtKB:O08573,
CC       ECO:0000250|UniProtKB:P97840}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:O00182}. Nucleus
CC       {ECO:0000250|UniProtKB:O00182}. Secreted
CC       {ECO:0000250|UniProtKB:O00182}. Note=May also be secreted by a non-
CC       classical secretory pathway. Secreted by mesenchymal stromal cells upon
CC       IFNG stimulation. {ECO:0000250|UniProtKB:O00182,
CC       ECO:0000250|UniProtKB:O08573}.
CC   -!- DOMAIN: Contains two homologous but distinct carbohydrate-binding
CC       domains.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC104505; AAI04506.1; -; mRNA.
DR   RefSeq; NP_001034266.1; NM_001039177.2.
DR   AlphaFoldDB; Q3MHZ8; -.
DR   SMR; Q3MHZ8; -.
DR   STRING; 9913.ENSBTAP00000009025; -.
DR   PaxDb; Q3MHZ8; -.
DR   PRIDE; Q3MHZ8; -.
DR   GeneID; 510813; -.
DR   KEGG; bta:510813; -.
DR   CTD; 3965; -.
DR   eggNOG; KOG3587; Eukaryota.
DR   InParanoid; Q3MHZ8; -.
DR   OrthoDB; 829777at2759; -.
DR   Proteomes; UP000009136; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0030246; F:carbohydrate binding; ISS:UniProtKB.
DR   GO; GO:0002376; P:immune system process; IEA:UniProtKB-KW.
DR   CDD; cd00070; GLECT; 2.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR044156; Galectin-like.
DR   InterPro; IPR001079; Galectin_CRD.
DR   PANTHER; PTHR11346; PTHR11346; 1.
DR   Pfam; PF00337; Gal-bind_lectin; 2.
DR   SMART; SM00908; Gal-bind_lectin; 2.
DR   SMART; SM00276; GLECT; 2.
DR   SUPFAM; SSF49899; SSF49899; 2.
DR   PROSITE; PS51304; GALECTIN; 2.
PE   2: Evidence at transcript level;
KW   Cytoplasm; Immunity; Lectin; Nucleus; Reference proteome; Repeat; Secreted.
FT   CHAIN           1..355
FT                   /note="Galectin-9"
FT                   /id="PRO_0000283031"
FT   DOMAIN          17..148
FT                   /note="Galectin 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00639"
FT   DOMAIN          227..355
FT                   /note="Galectin 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00639"
FT   BINDING         48
FT                   /ligand="a beta-D-galactoside"
FT                   /ligand_id="ChEBI:CHEBI:28034"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         61
FT                   /ligand="a beta-D-galactoside"
FT                   /ligand_id="ChEBI:CHEBI:28034"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         65
FT                   /ligand="a beta-D-galactoside"
FT                   /ligand_id="ChEBI:CHEBI:28034"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         75
FT                   /ligand="a beta-D-galactoside"
FT                   /ligand_id="ChEBI:CHEBI:28034"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         82..88
FT                   /ligand="a beta-D-galactoside"
FT                   /ligand_id="ChEBI:CHEBI:28034"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         267
FT                   /ligand="a beta-D-galactoside"
FT                   /ligand_id="ChEBI:CHEBI:28034"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         271
FT                   /ligand="a beta-D-galactoside"
FT                   /ligand_id="ChEBI:CHEBI:28034"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         281
FT                   /ligand="a beta-D-galactoside"
FT                   /ligand_id="ChEBI:CHEBI:28034"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         287..293
FT                   /ligand="a beta-D-galactoside"
FT                   /ligand_id="ChEBI:CHEBI:28034"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   355 AA;  39334 MW;  FB56142FC54747FB CRC64;
     MAFGGAQASY INPVVPFTGM IQGGLQDGHK ITIIGAVLPS GGNRFAVNLQ TGYNDSDIAF
     HFNPRFEEGG YVVCNTKQRG SWGTEERKMH MPFQRGCSFE LCFQVQSSDF RVMVNGNLFT
     QYAHRVPFHR IDAISITGVV QLSSISFQNI RAAPKQPACS KVQFSQAVCL PPRPRGRKSN
     PPGIWPANSA PIAQTFVHTI HSAPGQMFPN PVIPPAVYPN PVYQLPFFTS ILGGLYPSKS
     ILVSGTILPS AQRFYINLRS GSDIAFHLNP RFNENAVVRN TQINGSWGSE ERSLPRGMPF
     FRGQSFSVWI MCEGHCFKVA VDSQHLFEYH HRLKNLPAIN NLEVGGDIQL THVQT
//
